Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2007
03/01/2007US20070049574 4,5-Dicyclopropyl-1-methyl-2-phenyl-1,2-dihydro-pyrazol-3-one; 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1); 4-Cyclopropyl-5-(2,2-difluoro-cyclopropyl)-1-methyl-2-(2-trifluoromethyl-phenyl)-1,2-dihydro-pyrazol-3-one;
03/01/2007US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors
03/01/2007CA2620254A1 P38 map kinase inhibitors and methods for using the same
03/01/2007CA2620106A1 P38 map kinase inhibitors and methods for using the same
03/01/2007CA2620105A1 P38 map kinase inhibitors and methods for using the same
03/01/2007CA2620104A1 Fused pyrazole as p38 map kinase inhibitors
03/01/2007CA2619972A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
03/01/2007CA2619660A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
03/01/2007CA2619366A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseases
03/01/2007CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
03/01/2007CA2618087A1 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase
02/2007
02/28/2007EP1757608A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments
02/28/2007EP1757607A1 N5-substituted benzo¬2,3|azepino¬4,5-b|indol-6-ones for treating tropical diseases
02/28/2007EP1757605A1 Cyclic amine compound
02/28/2007EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
02/28/2007EP1757591A1 Cinnamide compound
02/28/2007EP1757583A1 Process for producing cyclic n-hydroxyimide compound
02/28/2007EP1756115A2 A new route to formyl-porphyrins
02/28/2007EP1756114A2 Hiv integrase inhibitors
02/28/2007EP1756113A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation
02/28/2007EP1756112A1 Pyrrolobenzimidazolones and their use as antiproliferative agents
02/28/2007EP1756111A1 Alkyl substituted indoloquinoxalines
02/28/2007EP1756110A1 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT
02/28/2007EP1756109A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
02/28/2007EP1756107A2 Aryl-substituted piperazine derivatives
02/28/2007EP1756101A2 Androgen receptor modulators and method of treating disease using the same
02/28/2007EP1756069A2 Hiv integrase inhibitors
02/28/2007EP1756063A1 Amido compounds and their use as pharmaceuticals
02/28/2007EP1756052A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
02/28/2007EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
02/28/2007EP1425286B1 Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases
02/28/2007EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents
02/28/2007EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
02/28/2007EP1045838B1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
02/28/2007CN1922187A Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12] urils
02/28/2007CN1922186A Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
02/28/2007CN1922185A Pyrazolotriazines as kinase inhibitors
02/28/2007CN1922184A 7H-pyrrolopyrimidine derivatives
02/28/2007CN1922183A Nitrogenous fused heteroaromatic ring derivative
02/28/2007CN1922182A Pyrrolotriazine compounds as kinase inhibitors
02/28/2007CN1922181A Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
02/28/2007CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
02/28/2007CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor
02/28/2007CN1922171A Pyrimidine derivative
02/28/2007CN1922159A Benzamide derivatives and their use as glucokinase activating agents
02/28/2007CN1922155A Novel sulfone amide derivative
02/28/2007CN1922141A Novel heterocyclic compound
02/28/2007CN1921854A Heterocyclic GABAA subtype selective receptor modulators
02/28/2007CN1921846A Combinatorial therapy with an acetylcholinesterase inhibitor and (3AR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
02/28/2007CN1302002C Hydroxylamine esters as polymerization initiators
02/28/2007CN1301995C Process for producing phenserine and its analog
02/27/2007US7183417 Which has antitumor activity; starting from (2S, 3R)-methyl 2-(4-methoxybenzamido)-3-hydroxybutanoate and cyclizing to Methyl 4,5-dihydro-2 (4-methoxyphenyl)-5-methyloxazole-4-carboxylate
02/27/2007US7183412 Ester or amide derivatives
02/27/2007US7183374 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution
02/27/2007US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
02/27/2007US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders
02/27/2007US7183280 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
02/27/2007US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
02/27/2007US7183270 Cyclic derivatives as modulators of chemokine receptor activity
02/27/2007US7182958 With oral bioavailability; tadalafil; erectile dysfunction
02/22/2007WO2007022102A2 Pentacyclic kinase inhibitors
02/22/2007WO2007021574A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists
02/22/2007WO2007021464A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process
02/22/2007WO2007020960A1 Process for producing carbapenem derivatives through reactions without isolating intermediates
02/22/2007WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists
02/22/2007WO2007019674A1 Viral polymerase inhibitors
02/22/2007WO2006122740A3 7-amino-6-hetarylimidazolo[1,2-a]pyrimidine compounds and use thereof for controlling harmful fungi
02/22/2007WO2006068978A3 Dipeptidyl peptidase inhibitors
02/22/2007WO2005120516A3 Hiv integrase inhibitors
02/22/2007US20070043289 Method and Apparatus Including Use of Metalloporphyrins for Subsequent Optimization of Radiosurgery and Radiotherapy
02/22/2007US20070043065 Amide derivatives
02/22/2007US20070043064 7-Substituted 3-nitro-pyrazo[1,5-a] pyrimidines
02/22/2007US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease
02/22/2007US20070043052 Reverse-turn mimetics and method relating thereto
02/22/2007US20070043051 Methods and compositions of novel triazine compounds
02/22/2007US20070043031 Non-amide nonanes
02/22/2007US20070043017 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
02/22/2007US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties
02/22/2007US20070042909 Use of fused ring-1,2,4-benzotriazine derivatives as herbicides or plant growth regulators for the control of undesired plants or vegetation, compounds and compositions thereof, and processes for their preparation
02/22/2007US20070042439 Porphyrin compound containing biotinyl group and use thereof
02/22/2007US20070042412 Detection of biologically active compounds
02/22/2007US20070041909 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
02/22/2007CA2619276A1 Pentacyclic kinase inhibitors
02/22/2007CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists
02/22/2007CA2616318A1 Acetylenic piperazines as metabotropic glutamate receptor antagonists
02/22/2007CA2616308A1 Bicyclic piperazines as metabotropic glutamate receptor antagonists
02/21/2007EP1754739A1 Deuterated polyimides and derivatives thereof
02/21/2007EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
02/21/2007EP1753767A1 Bicyclic heterocycles as hiv integrase inhibitors
02/21/2007EP1753766A1 Tetraazabenzo(e)azulene derivatives and analogs thereof
02/21/2007EP1753765A1 Immuno inhibitory heterocyclic compounds
02/21/2007EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
02/21/2007EP1753729A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
02/21/2007EP1753468A2 Carboranylporphyrins and uses thereof
02/21/2007EP1753457A2 Cationic bacteriochlorophyll derivatives and uses thereof
02/21/2007EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors
02/21/2007CN1918173A Novel indeno[2,1a]indenes and isoindol[2,1-a]indoles
02/21/2007CN1918167A Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
02/21/2007CN1918166A 烟碱乙酰胆碱受体配体 Nicotinic acetylcholine receptor ligands
02/21/2007CN1918165A Azabicyclic heterocycles as cannabinoid receptor modulators